- Recommendation ID
- NG130/2
- Question
What is the effectiveness of oral tacrolimus and systemic (intramuscular/subcutaneous/oral) methotrexate in the induction of remission in mild-to-moderate ulcerative colitis unresponsive to aminosalicylates?
- Any explanatory notes
(if applicable) To find out why the committee made the research recommendation on immunomodulators for unresponsive ulcerative colitis see rationale and impact.
Source guidance details
- Comes from guidance
- Ulcerative colitis: management
- Number
- NG130
- Date issued
- May 2019
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 03/05/2019 |